Innovation Pharmaceuticals Inc (IPIX)

[Empiricst1]

"Secondary endpoints and data from the Compassionate Use has been really encouraging. Without doubt, a fair trial of many people and not just a handful will be really meaningful."

Really, Monroe1, don't you think anything of value in compassionate use would have been front page/major cable news blockbuster. If Brilacid had any merit it would have been sucked up by a BP by now, at least the coivd piece. Also, recall, we are still dealing with an IV, so the population of those treated is limited to those hospitalized and often sicker. There may be some beneficial effect from the growing number of out of facility, IV infusion "businesses." Just not sure how that will play out.